Clinical outcomes of lung transplant recipients with pre‐transplant <i>Mycobacterium avium</i> complex infection
The bilateral LTR in our cohort did not develop MAC-PD despite not receiving MAC treatment post-transplant. It is possible source control was achieved with native lung explantation. Our observations suggest patients may not uniformly require pre- or post-transplant MAC treatment if they are smear-negative and undergo bilateral LT.
Authors
- Jona Banzon
- Sonya Kothadia (ORCID: https://orcid.org/0000-0003-2430-7560)
- Cyndee Miranda (ORCID: https://orcid.org/0000-0002-1296-9105)
- L. Benninger (ORCID: https://orcid.org/0000-0002-1217-1910)
- Christine E. Koval (ORCID: https://orcid.org/0000-0002-8196-2601)
- Jem Marie Golbin
- Eric E. Cober
- Susan M. Harrington (ORCID: https://orcid.org/0000-0001-8112-0896)
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1111/tid.14361
- Citations
- 1
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.39